interventional
N/A
1 country
9
Can antibiotics be omitted in the treatment of uncomplicated acute appendicitis?
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 4, 2023
Actual (reported)The primary outcome is 30-day treatment success defined as resolution of acute appendicitis resulting in discharge from the hospital without appendectomy during the 30-day follow-up
Secondary endpoints include post-intervention complications (Clavien-Dindo classification), late recurrence of acute appendicitis after the 30-day follow-up, duration of hospital stay in hours, admission to hospital and reason for admission, readmissions to emergency department or hospitalization, VAS pain scores, quality of life (QOL, EQ-5D-5L), sick leave and overall treatment and societal costs
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
MOXIFLOXACIN
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
FILM-COATED TABLET
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
MOXIFLOXACIN
Named ingredient: Moxifloxacin
View registry recordRegistry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Oulu University Hospital
Oulu, 90220, Finland
Lahti Central Hospital
Lahti, 15850, Finland
Seinäjoki Central Hospital
Seinäjoki, 60220, Finland
Paulina Salminen
First Submitted
July 4, 2023
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Pori Central Hospital
Pori, 28500, Finland
Kuopio University Hospital
Kuopio, 70210, Finland
Mikkeli Central Hospital
Mikkeli, 50100, Finland
Turku University Hospital
Turku, 20520, Finland
Jyväskylä Central Hospital
Jyväskylä, 40620, Finland
Tampere University Hospital
Tampere, 33520, Finland